| List of Figures |
|
| Figure 1‑1: Anesthesia, Respiratory and Sleep Management Device Market Share Ranking by Segment, Global, 2023 (1 of 2) |
4 |
| Figure 1‑2: Anesthesia, Respiratory and Sleep Management Device Market Share Ranking by Segment, Global, 2023 (2 of 2) |
5 |
| Figure 1‑3: Companies Researched in This Report (1 of 2) |
6 |
| Figure 1‑4: Companies Researched in This Report (2 of 2) |
7 |
| Figure 1‑5: Factors Impacting the Anesthesia, Respiratory and Sleep Management Device Market by Segment, Global (1 of 2) |
8 |
| Figure 1‑6: Factors Impacting the Anesthesia, Respiratory and Sleep Management Device Market by Segment, Global (2 of 2) |
9 |
| Figure 1‑7: Recent Events in the Anesthesia, Respiratory and Sleep Management Device Market, Global, 2020 – 2024 (1 of 3) |
10 |
| Figure 1‑8: Recent Events in the Anesthesia, Respiratory and Sleep Management Device Market, Global, 2020 – 2024 (2 of 3) |
11 |
| Figure 1‑9: Recent Events in the Anesthesia, Respiratory and Sleep Management Device Market, Global, 2020 – 2024 (3 of 3) |
12 |
| Figure 1‑10: Anesthesia, Respiratory, and Sleep Management Device Markets Covered (1 of 2) |
13 |
| Figure 1‑11: Anesthesia, Respiratory and Sleep Management Device Markets Covered (2 of 2) |
14 |
| Figure 1‑12: Anesthesia, Respiratory, and Sleep Management Device Regions Covered, Global (1 of 2) |
15 |
| Figure 1‑13: Anesthesia, Respiratory, and Sleep Management Device Regions Covered, Global (2 of 2) |
16 |
| Figure 1‑14: Version History |
17 |
| Figure 2‑1: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Worst Case Scenario, Global, 2020 – 2030 (US$M) (1 of 2) |
37 |
| Figure 2‑2: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Worst Case Scenario, Global, 2020 – 2030 (US$M) (2 of 2) |
38 |
| Figure 2‑3: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Base Case Scenario, Global, 2020 – 2030 (US$M) (1 of 2) |
39 |
| Figure 2‑4: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Base Case Scenario, Global, 2020 – 2030 (US$M) (2 of 2) |
40 |
| Figure 2‑5: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Best Case Scenario, Global, 2020 – 2030 (US$M) (1 of 2) |
41 |
| Figure 2‑6: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Best Case Scenario, Global, 2020 – 2030 (US$M) (2 of 2) |
42 |
| Figure 4‑1: Anesthesia Delivery Unit by Company |
50 |
| Figure 4‑2: Anesthesia Monitor by Company |
52 |
| Figure 4‑3: Anesthesia Disposables by Company (1 of 3) |
56 |
| Figure 4‑4: Anesthesia Disposables by Company (2 of 3) |
57 |
| Figure 4‑5: Anesthesia Disposables by Company (3 of 3) |
58 |
| Figure 4‑6: Ventilators by Company (1 of 2) |
62 |
| Figure 4‑7: Ventilators by Company (2 of 2) |
63 |
| Figure 4‑8: Nebulizers by Company |
66 |
| Figure 4‑9: Respiratory Disposables by Company (1 of 4) |
69 |
| Figure 4‑10: Respiratory Disposables by Company (2 of 4) |
70 |
| Figure 4‑11: Respiratory Disposables by Company (3 of 4) |
71 |
| Figure 4‑12: Respiratory Disposables by Company (4 of 4) |
72 |
| Figure 4‑13: Oxygen Therapy Devices by Company (1 of 2) |
74 |
| Figure 4‑14: Oxygen Therapy Devices by Company (2 of 2) |
75 |
| Figure 4‑15: Therapeutic Sleep Management Devices by Company (1 of 2) |
78 |
| Figure 4‑16: Therapeutic Sleep Management Devices by Company (2 of 2) |
79 |
| Figure 4‑17: Sleep Diagnostic Devices by Company (1 of 2) |
81 |
| Figure 4‑18: Sleep Diagnostic Devices by Company (2 of 2) |
82 |
| Figure 4‑19: Class 2 Device Recall GE Healthcare Avance and Aisys |
83 |
| Figure 4‑20: Class 1 Device Recall GE Healthcare Aisys and Avance |
83 |
| Figure 4‑21: Class 2 Device Recall Fabius MRI |
83 |
| Figure 4‑22: Class 2 Device Recall Aestiva 7900 |
84 |
| Figure 4‑23: Class 2 Device Recall Aisys CS2 |
84 |
| Figure 4‑24: Class 2 Device Recall Aestiva MRI |
84 |
| Figure 4‑25: Class 1 Device Recall Carestation 620/650/650c A1 |
84 |
| Figure 4‑26: Class 2 Device Recall Philips EarlyVue VS30 Vitals monitor |
85 |
| Figure 4‑27: Class 2 Device Recall Draeger Infinity M300 |
85 |
| Figure 4‑28: Class 2 Device Recall Draeger Infinity CentralStation |
85 |
| Figure 4‑29: Class 2 Device Recall GE |
86 |
| Figure 4‑30: Class 2 Device Recall IntelliVue MX40 Patient Monitor |
86 |
| Figure 4‑31: Class 2 Device Recall Mindray BeneVision Distributed Monitoring System (DMS) |
86 |
| Figure 4‑32: Class 2 Device Recall Philips IntelliVue X2 |
87 |
| Figure 4‑33: Class 2 Device Recall Philips IntelliVue MP2 |
87 |
| Figure 4‑34: Class 2 Device Recall IntelliVue |
87 |
| Figure 4‑35: Class 2 Device Recall IntelliVue MX800 |
87 |
| Figure 4‑36: Class 2 Device Recall IntelliVue |
88 |
| Figure 4‑37: Class 2 Device Recall Philips SureSigns |
88 |
| Figure 4‑38: Class 1 Device Recall CARESCAPE Respiratory Module EsCOVX |
88 |
| Figure 4‑39: Class 2 Device Recall Rosebud Vital Signs Monitor |
89 |
| Figure 4‑40: Class 1 Device Recall VentStar Coax |
90 |
| Figure 4‑41: Class 2 Device Recall Intersurgical Laryngeal Mask |
90 |
| Figure 4‑42: Class 2 Device Recall RUSCH Endotracheal Tube oral/nasal Magill, High Volume, Low Pressure Cuff |
90 |
| Figure 4‑43: Class 2 Device Recall VentStar |
91 |
| Figure 4‑44: Class 2 Device Recall Smoothbore breathing system with exhalation port 22 mm |
91 |
| Figure 4‑45: Class 1 Device Recall Oxylog 3000 Plus Emergency and Transport Ventilator |
92 |
| Figure 4‑46: Class 2 Device Recall Vyaire MEDICAL |
92 |
| Figure 4‑47: Class 1 Device Recall Trilogy EV300 |
92 |
| Figure 4‑48: Class 1 Device Recall Philips Respironics V680 Plus Ventilator |
93 |
| Figure 4‑49: Class 2 Device Recall Draeger |
93 |
| Figure 4‑50: Class 1 Device Recall Bellavista |
93 |
| Figure 4‑51: Class 2 Device Recall Draeger |
93 |
| Figure 4‑52: Class 1 Device Recall Philips Respironics E30 with Humidifier |
94 |
| Figure 4‑53: Class 1 Device Recall Trilogy 100, Trilogy 200, Garbin Plus, Aeris, LifeVent Continuous Ventilators |
94 |
| Figure 4‑54: Class 2 Device Recall Evita V800 Ventilator |
94 |
| Figure 4‑55: Class 2 Device Recall Evita V600 Ventilator |
94 |
| Figure 4‑56: Class 2 Device Recall Babylog VN600 Ventilator |
95 |
| Figure 4‑57: Class 2 Device Recall Babylog VN800 Ventilator |
95 |
| Figure 4‑58: Class 2 Device Recall Draeger |
95 |
| Figure 4‑59: Class 2 Device Recall Servo-i |
95 |
| Figure 4‑60: Class 1 Device Recall Trilogy EVO |
96 |
| Figure 4‑61: Class 1 Device Recall Stellar 150 |
96 |
| Figure 4‑62: Class 2 Device Recall bellavista Ventilator |
97 |
| Figure 4‑63: Class 2 Device Recall Oral/Nasal Tracheal Tube |
98 |
| Figure 4‑64: Class 2 Device Recall OxyMask |
98 |
| Figure 4‑65: Class 2 Device Recall Bivona Cuffless Adjustable Neck Flange Hyperflex Pediatric Tracheostomy Tubes |
98 |
| Figure 4‑66: Class 2 Device Recall RUSCH LASERTUBE |
98 |
| Figure 4‑67: Class 2 Device Recall Bivona Tracheostomy Tubes |
99 |
| Figure 4‑68: Class 1 Device Recall Hudson RCI Sheridan LTS |
99 |
| Figure 4‑69: Class 2 Device Recall Tube, Tracheal Bronchial |
99 |
| Figure 4‑70: Class 2 Device Recall RUSCH LASERTUBE |
100 |
| Figure 4‑71: Class 1 Device Recall HUDSON RDI NEONATAL ConchaSmart Breathing Circuit |
100 |
| Figure 4‑72: Class 1 Device Recall Hudson RCI Sheridan LTS |
100 |
| Figure 4‑73: Class 2 Device Recall Philips Respironics V60 Ventilator |
101 |
| Figure 4‑74: Class 2 Device Recall 1025 SERIES OXYGEN CONCENTRATOR |
101 |
| Figure 4‑75: Class 2 Device Recall DeVilbiss |
101 |
| Figure 4‑76: Class 2 Device Recall Drive DeVilbiss iGo 2 Portable Oxygen Concentrator |
101 |
| Figure 4‑77: Class 3 Device Recall Invacare Platinum 5NXG Oxygen Concentrator |
102 |
| Figure 4‑78: Class 2 Device Recall FreeStyle Comfort |
102 |
| Figure 4‑79: Class 1 Device Recall Philips Respironics V60 Ventilator |
102 |
| Figure 4‑80: Class 1 Device Recall Respironics Model V60 Plus Ventilator |
102 |
| Figure 4‑81: Class 2 Device Recall Invacare PerfectO2 V Oxygen Concentrator |
103 |
| Figure 4‑82: Class 2 Device Recall FreeStyle Comfort Oxygen Concentrator |
103 |
| Figure 4‑83: Class 2 Device Recall SAROS Oxygen System Model 3000 |
103 |
| Figure 4‑84: Class 1 Device Recall DreamStation1 (Uno Remediated Device) |
104 |
| Figure 4‑85: Class 1 Device Recall DreamWear |
104 |
| Figure 4‑86: Class 1 Device Recall DreamWisp |
104 |
| Figure 4‑87: Class 1 Device Recall ASeries BiPAP A40, and ASeries BiPAP A30 Continuous Ventilator |
105 |
| Figure 4‑88: Class 1 Device Recall DreamStation ASV, DreamStation ST, AVAPS, SystemOne ASV4, CSeries ASV, CSeries S/T and AVAPS, Omni |
105 |
| Figure 4‑89: Class 1 Device Recall DreamStation, DreamStation Go, Dorma 400, Dorma 500, and REMstar SE Auto |
105 |
| Figure 4‑90: Class 2 Device Recall BiPAP A40 System Silver, JP |
106 |
| Figure 4‑91: Class 2 Device Recall BiPAP V30 Auto System/BiPAP V30 Auto Ventilator, Domestic |
106 |
| Figure 4‑92: Class 2 Device Recall PSG1100 Sleep Diagnostic System |
107 |
| Figure 4‑93: I-gel vs Ambu AuraGain in Laparoscopic Gynecological Surgery |
109 |
| Figure 4‑94: Comparation of Proseal Laryngeal Mask Airway with Flexible Laryngeal Airway Mask |
109 |
| Figure 4‑95: Effect of Head Rotation on Efficacy of Face Mask Ventilation in Anesthetized Obese (BMI ≥ 35) Adults |
110 |
| Figure 4‑96: Ambu AuraGain and Teleflex LMA Protector Fiberoptic Assessments in Elective Patients |
110 |
| Figure 4‑97: Evaluation of the Ambu® AuraGain in Ambulatory Surgery |
110 |
| Figure 4‑98: Effect of Heated Breathing Circuit on Intraoperative Core Temperature and Systemic Inflammation after Brain Surgery: A Prospective Randomized Study |
111 |
| Figure 4‑99: Heated Circuit on Sore Throat |
111 |
| Figure 4‑100: The Effect of Reinforced Endotracheal Tube on Post-operative Hoarseness Undergoing Thyroidectomy |
112 |
| Figure 4‑101: Comparison of Endotracheal Intubation Over the Aintree with Fiberoptic Bronchoskop Via the I-gel and LMA Protector |
112 |
| Figure 4‑102: Pre-hospital Ventilation Clinical Study |
113 |
| Figure 4‑103: Comparison of Gas Exchange Between Two Invasive Mechanical Ventilation Modes in Children (CoCO2) |
113 |
| Figure 4‑104: Post Market, Prospective Multicenter Observational Study of the Safety and Performance of bellavista Ventilator |
114 |
| Figure 4‑105: Use of Airway Pressure Release Ventilation in Morbidly Obese Patients Undergoing Open Heart Surgery |
114 |
| Figure 4‑106: NPPV vs IPPV in Severe Chronic Obstructive Pulmonary Disease Exacerbation |
115 |
| Figure 4‑107: Noninvasive Ventilation Therapy for the Treatment of Pleural Effusion in Patients with Heart Failure |
115 |
| Figure 4‑108: Wean Early with HFNCO vs NPPV in Patients with AHRF |
116 |
| Figure 4‑109: SuperNO2VA™ and General Anesthesia Postoperative Care |
116 |
| Figure 4‑110: Jet or Vibrating Mesh Nebulisation for Secretion Management in ICU |
117 |
| Figure 4‑111: The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment |
117 |
| Figure 4‑112: Trial in Non-cystic Fibrosis Bronchiectasis Patients with Chronic Lung Infections Treated with Colistimethate Sodium (PROMIS-2) |
118 |
| Figure 4‑113: A Study for the Assessment of the Benefits of a Novel Mesh Nebulizer in the Treatment of Patients with Stable COPD |
118 |
| Figure 4‑114: SpeakFree Heat and Moisture Exchanger (HME) (SPEAKFREE) |
119 |
| Figure 4‑115: Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients |
119 |
| Figure 4‑116: The Effects Incentive Spirometry Use in Coronary Artery Bypass Surgery |
120 |
| Figure 4‑117: Comparison of High Flow Nasal Cannula Therapy to Nasal Oxygen as a Treatment for Obstructive Sleep Apnea in Infants |
120 |
| Figure 4‑118: Comparison of High-Flow Nasal Cannula Oxygen Application and Classic Nasal Cannula Oxygen Application |
121 |
| Figure 4‑119: Comparison of High Flow Nasal Cannula and Standard Face Mask Oxygen Therapy in Children with Bronchiolitis |
121 |
| Figure 4‑120: Non Invasive Mechanical Ventilation VERSUS Oxygen MASK |
122 |
| Figure 4‑121: Portable Oxygen Concentrator in Non-hospitalized Patients with Chronic Heart Failure |
123 |
| Figure 4‑122: Efficacy of High Flow Nasal Oxygen Therapy Started in the Emergency Room Versus Conventional Oxygen Therapy in Patients with Acute Hypoxemic Respiratory Distress |
123 |
| Figure 4‑123: Portable Oxygen Concentrator (POC) Versus Standard of Care in Long-COVID: Randomized Crossover Exploratory Pilot Study |
124 |
| Figure 4‑124: Nasal Oxygen Therapy after Cardiac Surgery (NOTACS) |
124 |
| Figure 4‑125: Automatic Oxygen Control for Reducing Extremes of Oxygen Saturation (AreOS): A Randomised Control Trial (AreOS) |
125 |
| Figure 4‑126: Evaluation of a Portable Oxygen Concentrator During Ambulation for Patients Who Require Supplemental Oxygen (POC-LEAN) |
125 |
| Figure 4‑127: Usability Evaluation of a Portable Oxygen Concentrator |
126 |
| Figure 4‑128: A Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose |
127 |
| Figure 4‑129: Long-Term Observation of PAP-Therapy with Telemonitoring: Telemedicine Registry TelePAP (TelePAP) |
127 |
| Figure 4‑130: 3D Printing of Positive Airway Pressure (PAP) Therapy Masks: A Single Site Pilot and Feasibility Study |
128 |
| Figure 4‑131: Effects of Continuous Positive Airway Pressure Therapy Withdrawal in Patients with Obstructive Sleep Apnea: A Randomized Trial |
128 |
| Figure 4‑132: Efficacy and Safety of keepMED Positive Airway Pressure Device in Patients with Obstructive Sleep Apnea |
129 |
| Figure 4‑133: A Prospective Multicenter Registry of Patients with Sleep Disordered Breathing Treated with DreamStation BiPAP autoSV (autoSVREGDE) |
129 |
| Figure 4‑134: Auto-PAP Therapy for Improved Fetal Growth |
130 |
| Figure 4‑135: Obstructive Sleep Apnea Syndrome: Evaluation of the Efficacy of Sleepinnov© (Spiri+) Continuous Positive Airway Pressure Device (Spiri+) |
130 |
| Figure 4‑136: Therapy Adherence Management in Veterans |
131 |
| Figure 4‑137: Comparison of Sleep Apnea Assessment Strategies to Maximize TBI Rehabilitation Participation and Outcome (C-SAS) |
131 |
| Figure 4‑138: Positive Airway Pressure Treatment of Obstructive Sleep-disordered Breathing in Hypertensive Disorders of Pregnancy |
132 |
| Figure 4‑139: European Registry on the Treatment of Central and Complex Sleep-Disordered Breathing with Adaptive Servo-Ventilation (READ-ASV) |
132 |
| Figure 4‑140: Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone: Impact of APAP vs CPAP |
133 |
| Figure 4‑141: CPAP for OSA on Myocardial Salvage after pPCI for STEMI Patients |
133 |
| Figure 4‑142: Home Apnea Testing in CHildren Trial (HATCH) |
134 |
| Figure 4‑143: Validation of an Integrated Digital Solution (SUNrise®) Versus Polysomnography for Obstructive Sleep Apnea Diagnosis |
134 |
| Figure 4‑144: Comparative Assessment of Compumedics Somfit Sleep Monitoring Device |
135 |
| Figure 4‑145: A Validation Study of the NightOwl Home Sleep Apnea Test |
135 |
| Figure 4‑146: Validation of ApneaLink Air Home Sleep Testing in the Diagnosis of Obstructive Sleep Apnea in Adolescent Children |
135 |
| Figure 4‑147: ApneaLink Air Home Sleep Testing (HST) Device Validation Study |
136 |
| Figure 5‑1: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Global, 2020 – 2030 (US$M) (1 of 2) |
140 |
| Figure 5‑2: Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Global, 2020 – 2030 (US$M) (2 of 2) |
141 |
| Figure 5‑3: Anesthesia, Respiratory, and Sleep Management Device Market by Region, Global, 2020 – 2030 (US$M) |
144 |
| Figure 5‑4: Leading Competitors, Anesthesia, Respiratory, and Sleep Management Device Market by Segment, Global, 2023 (1 of 2) |
157 |
| Figure 5‑5: SWOT Analysis, Ambu |
175 |
| Figure 5‑6: SWOT Analysis, Dräger Medical |
176 |
| Figure 5‑7: SWOT Analysis, Fisher & Paykel |
177 |
| Figure 5‑8: SWOT Analysis, GE Healthcare (1 of 2) |
178 |
| Figure 5‑9: SWOT Analysis, GE Healthcare (2 of 2) |
179 |
| Figure 5‑10: SWOT Analysis, Inogen |
180 |
| Figure 5‑11: SWOT Analysis, Medtronic |
181 |
| Figure 5‑12: SWOT Analysis, Omron |
182 |
| Figure 5‑13: SWOT Analysis, Philips |
183 |
| Figure 5‑14: SWOT Analysis, ResMed |
184 |
| Figure 5‑15: SWOT Analysis, Teleflex |
185 |
| Figure 5‑16: SWOT Analysis, Vyaire |
186 |
| Figure 6‑1: Anesthesia Delivery Unit Markets Covered |
191 |
| Figure 6‑2: Anesthesia Delivery Unit Regions Covered, Global (1 of 2) |
192 |
| Figure 6‑3: Anesthesia Delivery Unit Regions Covered, Global (2 of 2) |
193 |
| Figure 6‑4: Anesthesia Delivery Unit Market by Segment, Global, 2020 – 2030 (US$M) |
197 |
| Figure 6‑5: Anesthesia Delivery Unit Market by Region, Global, 2020 – 2030 (US$M) |
199 |
| Figure 6‑6: Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
202 |
| Figure 6‑7: Units Sold by Region, Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
203 |
| Figure 6‑8: Average Selling Price by Region, Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$) |
204 |
| Figure 6‑9: Market Value by Region, Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$M) |
205 |
| Figure 6‑10: Installed Base by Region, Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
206 |
| Figure 6‑11: High-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
208 |
| Figure 6‑12: Units Sold by Region, High-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
209 |
| Figure 6‑13: Average Selling Price by Region, High-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$) |
210 |
| Figure 6‑14: Market Value by Region, High-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$M) |
211 |
| Figure 6‑15: Installed Base by Region, High-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
212 |
| Figure 6‑16: Low-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
214 |
| Figure 6‑17: Units Sold by Region, Low-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
215 |
| Figure 6‑18: Average Selling Price by Region, Low-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$) |
216 |
| Figure 6‑19: Market Value by Region, Low-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 (US$M) |
217 |
| Figure 6‑20: Installed Base by Region, Low-Complexity Hospital OR Anesthesia Delivery Unit Market, Global, 2020 – 2030 |
218 |
| Figure 6‑21: Leading Competitors, Anesthesia Delivery Unit Market, Global, 2023 |
223 |
| Figure 7‑1: Anesthesia Monitor Regions Covered, Global (1 of 2) |
229 |
| Figure 7‑2: Anesthesia Monitor Regions Covered, Global (2 of 2) |
230 |
| Figure 7‑3: Anesthesia Monitor Market, Global, 2020 – 2030 |
232 |
| Figure 7‑4: Units Sold by Region, Anesthesia Monitor Market, Global, 2020 – 2030 |
234 |
| Figure 7‑5: Average Selling Price by Region, Anesthesia Monitor Market, Global, 2020 – 2030 (US$) |
235 |
| Figure 7‑6: Market Value by Region, Anesthesia Monitor Market, Global, 2020 – 2030 (US$M) |
236 |
| Figure 7‑7: Leading Competitors, Anesthesia Monitor Market, Global, 2023 |
241 |
| Figure 8‑1: Anesthesia Disposables Markets Covered |
247 |
| Figure 8‑2: Anesthesia Disposables Regions Covered, Global (1 of 2) |
248 |
| Figure 8‑3: Anesthesia Disposables Regions Covered, Global (2 of 2) |
249 |
| Figure 8‑4: Anesthesia Disposables Market by Segment, Global, 2020 – 2030 (US$M) |
254 |
| Figure 8‑5: Anesthesia Disposables Market by Region, Global, 2020 – 2030 (US$M) |
256 |
| Figure 8‑6: Anesthesia Disposables Market, Global, 2020 – 2030 |
258 |
| Figure 8‑7: Units Sold by Region, Anesthesia Disposables Market, Global, 2020 – 2030 |
259 |
| Figure 8‑8: Average Selling Price by Region, Anesthesia Disposables Market, Global, 2020 – 2030 (US$) |
260 |
| Figure 8‑9: Market Value by Region, Anesthesia Disposables Market, Global, 2020 – 2030 (US$M) |
261 |
| Figure 8‑10: Anesthesia Circuit Market, Global, 2020 – 2030 |
262 |
| Figure 8‑11: Units Sold by Region, Anesthesia Circuit Market, Global, 2020 – 2030 |
263 |
| Figure 8‑12: Average Selling Price by Region, Anesthesia Circuit Market, Global, 2020 – 2030 (US$) |
264 |
| Figure 8‑13: Market Value by Region, Anesthesia Circuit Market, Global, 2020 – 2030 (US$M) |
265 |
| Figure 8‑14: Anesthesia Mask Market, Global, 2020 – 2030 |
266 |
| Figure 8‑15: Units Sold by Region, Anesthesia Mask Market, Global, 2020 – 2030 |
267 |
| Figure 8‑16: Average Selling Price by Region, Anesthesia Mask Market, Global, 2020 – 2030 (US$) |
268 |
| Figure 8‑17: Market Value by Region, Anesthesia Mask Market, Global, 2020 – 2030 (US$M) |
269 |
| Figure 8‑18: Endotracheal Tube Market, Global, 2020 – 2030 |
270 |
| Figure 8‑19: Units Sold by Region, Endotracheal Tube Market, Global, 2020 – 2030 |
271 |
| Figure 8‑20: Average Selling Price by Region, Endotracheal Tube Market, Global, 2020 – 2030 (US$) |
272 |
| Figure 8‑21: Market Value by Region, Endotracheal Tube Market, Global, 2020 – 2030 (US$M) |
273 |
| Figure 8‑22: Laryngeal Mask Market by Segment, Global, 2020 – 2030 (US$M) |
274 |
| Figure 8‑23: Total Laryngeal Mask Market, Global, 2020 – 2030 |
275 |
| Figure 8‑24: Units Sold by Region, Laryngeal Mask Market, Global, 2020 – 2030 |
276 |
| Figure 8‑25: Average Selling Price by Region, Laryngeal Mask Market, Global, 2020 – 2030 (US$) |
277 |
| Figure 8‑26: Market Value by Region, Laryngeal Mask Market, Global, 2020 – 2030 (US$M) |
278 |
| Figure 8‑27: Disposable Laryngeal Mask Market, Global, 2020 – 2030 |
279 |
| Figure 8‑28: Units Sold by Region, Disposable Laryngeal Mask Market, Global, 2020 – 2030 |
280 |
| Figure 8‑29: Average Selling Price by Region, Disposable Laryngeal Mask Market, Global, 2020 – 2030 (US$) |
281 |
| Figure 8‑30: Market Value by Region, Disposable Laryngeal Mask Market, Global, 2020 – 2030 (US$M) |
282 |
| Figure 8‑31: Reusable Laryngeal Mask Market, Global, 2020 – 2030 |
283 |
| Figure 8‑32: Units Sold by Region, Reusable Laryngeal Mask Market, Global, 2020 – 2030 |
284 |
| Figure 8‑33: Average Selling Price by Region, Reusable Laryngeal Mask Market, Global, 2020 – 2030 (US$) |
285 |
| Figure 8‑34: Market Value by Region, Reusable Laryngeal Mask Market, Global, 2020 – 2030 (US$M) |
286 |
| Figure 8‑35: Leading Competitors, Anesthesia Disposables Market, Global, 2023 |
292 |
| Figure 9‑1: Ventilator Markets Covered |
298 |
| Figure 9‑2: Ventilator Regions Covered, Global (1 of 2) |
299 |
| Figure 9‑3: Ventilator Regions Covered, Global (2 of 2) |
300 |
| Figure 9‑4: Ventilator Market by Segment, Global, 2020 – 2030 (US$M) |
304 |
| Figure 9‑5: Ventilator Market by Region, Global, 2020 – 2030 (US$M) |
306 |
| Figure 9‑6: Ventilator Market, Global, 2020 – 2030 |
308 |
| Figure 9‑7: Units Sold by Region, Ventilator Market, Global, 2020 – 2030 |
309 |
| Figure 9‑8: Average Selling Price by Region, Ventilator Market, Global, 2020 – 2030 (US$) |
310 |
| Figure 9‑9: Market Value by Region, Ventilator Market, Global, 2020 – 2030 (US$M) |
311 |
| Figure 9‑10: Installed Base by Region, Ventilator Market, Global, 2020 – 2030 |
312 |
| Figure 9‑11: Acute Care Ventilator Market, Global, 2020 – 2030 |
313 |
| Figure 9‑12: Units Sold by Region, Acute Care Ventilator Market, Global, 2020 – 2030 |
314 |
| Figure 9‑13: Average Selling Price by Region, Acute Care Ventilator Market, Global, 2020 – 2030 (US$) |
315 |
| Figure 9‑14: Market Value by Region, Acute Care Ventilator Market, Global, 2020 – 2030 (US$M) |
316 |
| Figure 9‑15: Installed Base by Region, Acute Care Ventilator Market, Global, 2020 – 2030 |
317 |
| Figure 9‑16: Sub-Acute Care Ventilator Market, Global, 2020 – 2030 |
318 |
| Figure 9‑17: Units Sold by Region, Sub-Acute Care Ventilator Market, Global, 2020 – 2030 |
319 |
| Figure 9‑18: Average Selling Price by Region, Sub-Acute Care Ventilator Market, Global, 2020 – 2030 (US$) |
320 |
| Figure 9‑19: Market Value by Region, Sub-Acute Care Ventilator Market, Global, 2020 – 2030 (US$M) |
321 |
| Figure 9‑20: Installed Base by Region, Sub-Acute Care Ventilator Market, Global, 2020 – 2030 |
322 |
| Figure 9‑21: Home Care Ventilator Market, Global, 2020 – 2030 |
323 |
| Figure 9‑22: Units Sold by Region, Home Care Ventilator Market, Global, 2020 – 2030 |
324 |
| Figure 9‑23: Average Selling Price by Region, Home Care Ventilator Market, Global, 2020 – 2030 (US$) |
325 |
| Figure 9‑24: Market Value by Region, Home Care Ventilator Market, Global, 2020 – 2030 (US$M) |
326 |
| Figure 9‑25: Installed Base by Region, Home Care Ventilator Market, Global, 2020 – 2030 |
327 |
| Figure 9‑26: Neonatal Ventilator Market, Global, 2020 – 2030 |
328 |
| Figure 9‑27: Units Sold by Region, Neonatal Ventilator Market, Global, 2020 – 2030 |
329 |
| Figure 9‑28: Average Selling Price by Region, Neonatal Ventilator Market, Global, 2020 – 2030 (US$) |
330 |
| Figure 9‑29: Market Value by Region, Neonatal Ventilator Market, Global, 2020 – 2030 (US$M) |
331 |
| Figure 9‑30: Installed Base by Region, Neonatal Ventilator Market, Global, 2020 – 2030 |
332 |
| Figure 9‑31: Non-Invasive Ventilator Market, Global, 2020 – 2030 |
333 |
| Figure 9‑32: Units Sold by Region, Non-Invasive Ventilator Market, Global, 2020 – 2030 |
334 |
| Figure 9‑33: Average Selling Price by Region, Non-Invasive Ventilator Market, Global, 2020 – 2030 (US$) |
335 |
| Figure 9‑34: Market Value by Region, Non-Invasive Ventilator Market, Global, 2020 – 2030 (US$M) |
336 |
| Figure 9‑35: Installed Base by Region, Non-Invasive Ventilator Market, Global, 2020 – 2030 |
337 |
| Figure 9‑36: Leading Competitors, Ventilator Market, Global, 2023 |
344 |
| Figure 10‑1: Nebulizer Markets Covered |
350 |
| Figure 10‑2: Nebulizer Regions Covered, Global (1 of 2) |
351 |
| Figure 10‑3: Nebulizer Regions Covered, Global (2 of 2) |
352 |
| Figure 10‑4: Nebulizer Market by Segment, Global, 2020 – 2030 (US$M) |
356 |
| Figure 10‑5: Nebulizer Market by Region, Global, 2020 – 2030 (US$M) |
358 |
| Figure 10‑6: Nebulizer Market, Global, 2020 – 2030 |
360 |
| Figure 10‑7: Units Sold by Region, Nebulizer Market, Global, 2020 – 2030 |
361 |
| Figure 10‑8: Average Selling Price by Region, Nebulizer Market, Global, 2020 – 2030 (US$) |
362 |
| Figure 10‑9: Market Value by Region, Nebulizer Market, Global, 2020 – 2030 (US$M) |
363 |
| Figure 10‑10: Compressor/Jet Nebulizer Market by Segment, Global, 2020 – 2030 (US$M) |
364 |
| Figure 10‑11: Total Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
365 |
| Figure 10‑12: Units Sold by Region, Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
366 |
| Figure 10‑13: Average Selling Price by Region, Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$) |
367 |
| Figure 10‑14: Market Value by Region, Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$M) |
368 |
| Figure 10‑15: Stationary Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
369 |
| Figure 10‑16: Units Sold by Region, Stationary Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
370 |
| Figure 10‑17: Average Selling Price by Region, Stationary Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$) |
371 |
| Figure 10‑18: Market Value by Region, Stationary Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$M) |
372 |
| Figure 10‑19: Portable Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
373 |
| Figure 10‑20: Units Sold by Region, Portable Compressor/Jet Nebulizer Market, Global, 2020 – 2030 |
374 |
| Figure 10‑21: Average Selling Price by Region, Portable Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$) |
375 |
| Figure 10‑22: Market Value by Region, Portable Compressor/Jet Nebulizer Market, Global, 2020 – 2030 (US$M) |
376 |
| Figure 10‑23: Vibrating Nebulizer Market by Segment, Global, 2020 – 2030 (US$M) |
377 |
| Figure 10‑24: Total Vibrating Nebulizer Market, Global, 2020 – 2030 |
378 |
| Figure 10‑25: Units Sold by Region, Vibrating Nebulizer Market, Global, 2020 – 2030 |
379 |
| Figure 10‑26: Average Selling Price by Region, Vibrating Nebulizer Market, Global, 2020 – 2030 (US$) |
380 |
| Figure 10‑27: Market Value by Region, Vibrating Nebulizer Market, Global, 2020 – 2030 (US$M) |
381 |
| Figure 10‑28: Ultrasonic Nebulizer Market, Global, 2020 – 2030 |
382 |
| Figure 10‑29: Units Sold by Region, Ultrasonic Nebulizer Market, Global, 2020 – 2030 |
383 |
| Figure 10‑30: Average Selling Price by Region, Ultrasonic Nebulizer Market, Global, 2020 – 2030 (US$) |
384 |
| Figure 10‑31: Market Value by Region, Ultrasonic Nebulizer Market, Global, 2020 – 2030 (US$M) |
385 |
| Figure 10‑32: Vibrating Mesh Nebulizer Market, Global, 2020 – 2030 |
386 |
| Figure 10‑33: Units Sold by Region, Vibrating Mesh Nebulizer Market, Global, 2020 – 2030 |
387 |
| Figure 10‑34: Average Selling Price by Region, Vibrating Mesh Nebulizer Market, Global, 2020 – 2030 (US$) |
388 |
| Figure 10‑35: Market Value by Region, Vibrating Mesh Nebulizer Market, Global, 2020 – 2030 (US$M) |
389 |
| Figure 10‑36: Leading Competitors, Nebulizer Market, Global, 2023 |
395 |
| Figure 11‑1: Respiratory Disposables Markets Covered |
401 |
| Figure 11‑2: Respiratory Disposables Regions Covered, Global (1 of 2) |
402 |
| Figure 11‑3: Respiratory Disposables Regions Covered, Global (2 of 2) |
403 |
| Figure 11‑4: Respiratory Disposables Market by Segment, Global, 2020 – 2030 (US$M) |
407 |
| Figure 11‑5: Respiratory Disposables Market by Region, Global, 2020 – 2030 (US$M) |
409 |
| Figure 11‑6: Respiratory Disposables Market, Global, 2020 – 2030 |
411 |
| Figure 11‑7: Units Sold by Region, Respiratory Disposables Market, Global, 2020 – 2030 |
412 |
| Figure 11‑8: Average Selling Price by Region, Respiratory Disposables Market, Global, 2020 – 2030 (US$) |
413 |
| Figure 11‑9: Market Value by Region, Respiratory Disposables Market, Global, 2020 – 2030 (US$M) |
414 |
| Figure 11‑10: Oxygen Cannula Market, Global, 2020 – 2030 |
415 |
| Figure 11‑11: Units Sold by Region, Oxygen Cannula Market, Global, 2020 – 2030 |
416 |
| Figure 11‑12: Average Selling Price by Region, Oxygen Cannula Market, Global, 2020 – 2030 (US$) |
417 |
| Figure 11‑13: Market Value by Region, Oxygen Cannula Market, Global, 2020 – 2030 (US$M) |
418 |
| Figure 11‑14: Oxygen Mask Market, Global, 2020 – 2030 |
419 |
| Figure 11‑15: Units Sold by Region, Oxygen Mask Market, Global, 2020 – 2030 |
420 |
| Figure 11‑16: Average Selling Price by Region, Oxygen Mask Market, Global, 2020 – 2030 (US$) |
421 |
| Figure 11‑17: Market Value by Region, Oxygen Mask Market, Global, 2020 – 2030 (US$M) |
422 |
| Figure 11‑18: Tracheostomy Tube Market, Global, 2020 – 2030 |
423 |
| Figure 11‑19: Units Sold by Region, Tracheostomy Tube Market, Global, 2020 – 2030 |
424 |
| Figure 11‑20: Average Selling Price by Region, Tracheostomy Tube Market, Global, 2020 – 2030 (US$) |
425 |
| Figure 11‑21: Market Value by Region, Tracheostomy Tube Market, Global, 2020 – 2030 (US$M) |
426 |
| Figure 11‑22: Resuscitator Market, Global, 2020 – 2030 |
427 |
| Figure 11‑23: Units Sold by Region, Resuscitator Market, Global, 2020 – 2030 |
428 |
| Figure 11‑24: Average Selling Price by Region, Resuscitator Market, Global, 2020 – 2030 (US$) |
429 |
| Figure 11‑25: Market Value by Region, Resuscitator Market, Global, 2020 – 2030 (US$M) |
430 |
| Figure 11‑26: Heat and Moisture Exchanger Market, Global, 2020 – 2030 |
431 |
| Figure 11‑27: Units Sold by Region, Heat and Moisture Exchanger Market, Global, 2020 – 2030 |
432 |
| Figure 11‑28: Average Selling Price by Region, Heat and Moisture Exchanger Market, Global, 2020 – 2030 (US$) |
433 |
| Figure 11‑29: Market Value by Region, Heat and Moisture Exchanger Market, Global, 2020 – 2030 (US$M) |
434 |
| Figure 11‑30: Leading Competitors, Respiratory Disposables Market, Global, 2023 |
440 |
| Figure 12‑1: Oxygen Concentrator Markets Covered |
447 |
| Figure 12‑2: Oxygen Concentrator Regions Covered, Global (1 of 2) |
448 |
| Figure 12‑3: Oxygen Concentrator Regions Covered, Global (2 of 2) |
449 |
| Figure 12‑4: Oxygen Concentrator Market by Segment, Global, 2020 – 2030 (US$M) |
452 |
| Figure 12‑5: Oxygen Concentrator Market by Region, Global, 2020 – 2030 (US$M) |
454 |
| Figure 12‑6: Oxygen Concentrator Market, Global, 2020 – 2030 |
457 |
| Figure 12‑7: Units Sold by Region, Oxygen Concentrator Market, Global, 2020 – 2030 |
458 |
| Figure 12‑8: Average Selling Price by Region, Oxygen Concentrator Market, Global, 2020 – 2030 (US$) |
459 |
| Figure 12‑9: Market Value by Region, Oxygen Concentrator Market, Global, 2020 – 2030 (US$M) |
460 |
| Figure 12‑10: Stationary Oxygen Concentrator Market, Global, 2020 – 2030 |
461 |
| Figure 12‑11: Units Sold by Region, Stationary Oxygen Concentrator Market, Global, 2020 – 2030 |
462 |
| Figure 12‑12: Average Selling Price by Region, Stationary Oxygen Concentrator Market, Global, 2020 – 2030 (US$) |
463 |
| Figure 12‑13: Market Value by Region, Stationary Oxygen Concentrator Market, Global, 2020 – 2030 (US$M) |
464 |
| Figure 12‑14: Portable Oxygen Concentrator Market, Global, 2020 – 2030 |
466 |
| Figure 12‑15: Units Sold by Region, Portable Oxygen Concentrator Market, Global, 2020 – 2030 |
467 |
| Figure 12‑16: Average Selling Price by Region, Portable Oxygen Concentrator Market, Global, 2020 – 2030 (US$) |
468 |
| Figure 12‑17: Market Value by Region, Portable Oxygen Concentrator Market, Global, 2020 – 2030 (US$M) |
469 |
| Figure 12‑18: Leading Competitors, Oxygen Concentrator Market, Global, 2023 |
474 |
| Figure 13‑1: Therapeutic Obstructive Sleep Apnea Device Markets Covered |
480 |
| Figure 13‑2: Therapeutic Obstructive Sleep Apnea Device Regions Covered, Global (1 of 2) |
481 |
| Figure 13‑3: Therapeutic Obstructive Sleep Apnea Device Regions Covered, Global (2 of 2) |
482 |
| Figure 13‑4: Therapeutic Obstructive Sleep Apnea Device Market by Segment, Global, 2020 – 2030 (US$M) |
487 |
| Figure 13‑5: Therapeutic Obstructive Sleep Apnea Device Market by Region, Global, 2020 – 2030 (US$M) |
489 |
| Figure 13‑6: Total Positive Airway Pressure Device Market by Segment, Global, 2020 – 2030 (US$M) |
492 |
| Figure 13‑7: Total Positive Airway Pressure Device Market, Global, 2020 – 2030 |
493 |
| Figure 13‑8: Units Sold by Region, Total Positive Airway Pressure Device Market, Global, 2020 – 2030 |
494 |
| Figure 13‑9: Average Selling Price by Region, Total Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$) |
495 |
| Figure 13‑10: Market Value by Region, Total Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$M) |
496 |
| Figure 13‑11: Continuous Positive Airway Pressure Device Market, Global, 2020 – 2030 |
497 |
| Figure 13‑12: Units Sold by Region, Continuous Positive Airway Pressure Device Market, Global, 2020 – 2030 |
498 |
| Figure 13‑13: Average Selling Price by Region, Continuous Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$) |
499 |
| Figure 13‑14: Market Value by Region, Continuous Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$M) |
500 |
| Figure 13‑15: Auto-Titrating Positive Airway Pressure Device Market, Global, 2020 – 2030 |
501 |
| Figure 13‑16: Units Sold by Region, Auto-Titrating Positive Airway Pressure Device Market, Global, 2020 – 2030 |
502 |
| Figure 13‑17: Average Selling Price by Region, Auto-Titrating Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$) |
503 |
| Figure 13‑18: Market Value by Region, Auto-Titrating Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$M) |
504 |
| Figure 13‑19: Bi-Level Positive Airway Pressure Device Market, Global, 2020 – 2030 |
505 |
| Figure 13‑20: Units Sold by Region, Bi-Level Positive Airway Pressure Device Market, Global, 2020 – 2030 |
506 |
| Figure 13‑21: Average Selling Price by Region, Bi-Level Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$) |
507 |
| Figure 13‑22: Market Value by Region, Bi-Level Positive Airway Pressure Device Market, Global, 2020 – 2030 (US$M) |
508 |
| Figure 13‑23: Total Sleep Therapy Interface Market by Segment, Global, 2020 – 2030 (US$M) |
510 |
| Figure 13‑24: Total Sleep Therapy Interface Market, Global, 2020 – 2030 |
510 |
| Figure 13‑25: Units Sold by Region, Total Sleep Therapy Interface Market, Global, 2020 – 2030 |
511 |
| Figure 13‑26: Average Selling Price by Region, Total Sleep Therapy Interface Market, Global, 2020 – 2030 (US$) |
512 |
| Figure 13‑27: Market Value by Region, Total Sleep Therapy Interface Market, Global, 2020 – 2030 (US$M) |
513 |
| Figure 13‑28: Nasal Mask Market, Global, 2020 – 2030 |
514 |
| Figure 13‑29: Units Sold by Region, Nasal Mask Market, Global, 2020 – 2030 |
515 |
| Figure 13‑30: Average Selling Price by Region, Nasal Mask Market, Global, 2020 – 2030 (US$) |
516 |
| Figure 13‑31: Market Value by Region, Nasal Mask Market, Global, 2020 – 2030 (US$M) |
517 |
| Figure 13‑32: Full-Face Mask Market, Global, 2020 – 2030 |
518 |
| Figure 13‑33: Units Sold by Region, Full-Face Mask Market, Global, 2020 – 2030 |
519 |
| Figure 13‑34: Average Selling Price by Region, Full-Face Mask Market, Global, 2020 – 2030 (US$) |
520 |
| Figure 13‑35: Market Value by Region, Full-Face Mask Market, Global, 2020 – 2030 (US$M) |
521 |
| Figure 13‑36: Nasal Pillow/Alternative Interface Mask Market, Global, 2020 – 2030 |
522 |
| Figure 13‑37: Units Sold by Region, Nasal Pillow/Alternative Interface Mask Market, Global, 2020 – 2030 |
523 |
| Figure 13‑38: Average Selling Price by Region, Nasal Pillow/Alternative Interface Mask Market, Global, 2020 – 2030 (US$) |
524 |
| Figure 13‑39: Market Value by Region, Nasal Pillow/Alternative Interface Mask Market, Global, 2020 – 2030 (US$M) |
525 |
| Figure 13‑40: Leading Competitors, Therapeutic Obstructive Sleep Apnea Device Market, Global, 2023 |
531 |
| Figure 14‑1: Sleep Diagnostics Device Markets Covered |
537 |
| Figure 14‑2: Sleep Diagnostics Device Regions Covered, Global (1 of 2) |
538 |
| Figure 14‑3: Sleep Diagnostics Device Regions Covered, Global (2 of 2) |
539 |
| Figure 14‑4: Sleep Diagnostics Device Market by Segment, Global, 2020 – 2030 (US$M) |
543 |
| Figure 14‑5: Sleep Diagnostics Device Market by Region, Global, 2020 – 2030 (US$M) |
545 |
| Figure 14‑6: Sleep Diagnostics Device Market, Global, 2020 – 2030 |
547 |
| Figure 14‑7: Units Sold by Region, Sleep Diagnostics Device Market, Global, 2020 – 2030 |
548 |
| Figure 14‑8: Average Selling Price by Region, Sleep Diagnostics Device Market, Global, 2020 – 2030 (US$) |
549 |
| Figure 14‑9: Market Value by Region, Sleep Diagnostics Device Market, Global, 2020 – 2030 (US$M) |
550 |
| Figure 14‑10: Polysomnography Device Market, Global, 2020 – 2030 |
551 |
| Figure 14‑11: Units Sold by Region, Polysomnography Device Market, Global, 2020 – 2030 |
552 |
| Figure 14‑12: Average Selling Price by Region, Polysomnography Device Market, Global, 2020 – 2030 (US$) |
553 |
| Figure 14‑13: Market Value by Region, Polysomnography Device Market, Global, 2020 – 2030 (US$M) |
554 |
| Figure 14‑14: Home Respiratory Polygraphy Device Market, Global, 2020 – 2030 |
555 |
| Figure 14‑15: Units Sold by Region, Home Respiratory Polygraphy Device Market, Global, 2020 – 2030 |
556 |
| Figure 14‑16: Average Selling Price by Region, Home Respiratory Polygraphy Device Market, Global, 2020 – 2030 (US$) |
557 |
| Figure 14‑17: Market Value by Region, Home Respiratory Polygraphy Device Market, Global, 2020 – 2030 (US$M) |
558 |
| Figure 14‑18: Leading Competitors, Sleep Diagnostics Device Market, Global, 2023 |
564 |
